Skip to main content
. 2023 Apr 19;14:1102094. doi: 10.3389/fimmu.2023.1102094

Figure 8.

Figure 8

Validation of the EIF2AK3 expression in glioma tissues and non-tumor tissue analyzed through RT-qPCR and IHC. (A) The mRNA expression level of EIF2AK3 in diffuse glioma with glioma and para-carcinoma tissues via RT-qPCR. (B) The mRNA expression level of EIF2AK3 in different grades of glioma samples via RT-qPCR. (C) The protein expression level of EIF2AK3 in diffuse glioma specimens with different grades has been analyzed via IHC staining. ns, P > 0.05; *P < 0.05; ***P < 0.001.